Comparing Innovative and Traditional Ventilation Strategies on Atelectasis and Prognosis in Elderly Patients

NCT ID: NCT06021249

Last Updated: 2023-09-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

304 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-28

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was divided into two parts, taking elderly patients undergoing general anesthesia surgery as the research subjects, through factorial design: 1. It was verified that in elderly patients undergoing general anesthesia surgery, innovative lung-protective ventilation strategies can reduce the occurrence of atelectasis and reduce the incidence of ventilator-related lung injury and postoperative pulmonary complications more than traditional lung-protective ventilation strategies; 2. On the basis of part one study proving that innovative lung-protective ventilation strategies can reduce the incidence of postoperative atelectasis and other complications in elderly patients undergoing general anesthesia surgery compared with traditional lung-protective ventilation strategies, further comparisons were made between the two factors of "positive pressure extubation" and "improved early postoperative respiratory training" in the innovative lung protective ventilation strategy, and whether there was an interaction between the two.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

More and more people need to undergo general anesthesia surgery at least once in the lifetime, and patients who undergo general anesthesia surgery often have postoperative pulmonary complications, and the occurrence of postoperative pulmonary complications is related to the prolongation of the patient's hospital stay and postoperative mortality. This is contrary to the current goal of rapid postoperative recovery.

The International Expert Consensus on Strategies for Pulmonary Protective Ventilation states that age \> 50 years is one of the greatest risk factors for postoperative pulmonary complications. This means that even older patients with largely unimpaired preoperative lung function are more likely to develop postoperative pulmonary complications than younger patients. Therefore, the investigators set the study to elderly patients undergoing general anesthesia surgery.

The traditional lung-protective ventilation strategies commonly used to reduce atelectasis and ventilator-related lung injury during general anesthesia surgery is controversial and mixed. Based on literature review and preliminary experiments, this study focuses on extubation and post-extubation, which is a critical period of atelectasis development, combines positive pressure extubation technology with improved postoperative early breathing training, replaces the controversial continuous positive airway pressure(CPAP)support and alveolar recruitment manoeuvres in traditional lung protective ventilation strategies, and explores a new respiratory management strategy with more operability and clinical effect to reduce complications such as postoperative atelectasis in elderly patients.

This study was originally a single-center clinical study and has been registered in the Chinese Clinical Trial Registry(Registration number:ChiCTR2300071364). It was later changed to a multi-center clinical study, so it was re-registered.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventilator-associated Lung Injury Atelectasis Postoperative Pulmonary Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group of Control (Part I experiment)

Traditional ventilation strategies

Group Type SHAM_COMPARATOR

Traditional ventilation strategies

Intervention Type PROCEDURE

1. Tidal volume:10ml/kg predicted body weight(PBW);
2. 0 cm H2O positive end expiratory pressure(PEEP);
3. negative pressure extubation

Group of traditional lung-protective ventilation (Part I experiment)

Traditional lung-protective ventilation strategies

Group Type EXPERIMENTAL

Traditional lung-protective ventilation strategies

Intervention Type PROCEDURE

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;
3. Ventilator-controlled recruitment manoeuvre;
4. CPAP;
5. negative pressure extubation

Group of innovative lung-protective ventilation (Part I experiment)

Innovative lung-protective ventilation strategies

Group Type EXPERIMENTAL

Innovative lung-protective ventilation strategies

Intervention Type PROCEDURE

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;
3. positive pressure extubation;
4. postoperative breathing training

Group of traditional & innovative ventilation (Part I experiment)

Traditional \& innovative lung protection ventilation strategies

Group Type EXPERIMENTAL

Traditional lung-protective ventilation strategies

Intervention Type PROCEDURE

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;
3. Ventilator-controlled recruitment manoeuvre;
4. CPAP;
5. negative pressure extubation

Innovative lung-protective ventilation strategies

Intervention Type PROCEDURE

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;
3. positive pressure extubation;
4. postoperative breathing training

Group of Control (Part II experiment)

1. lung-protective ventilation;
2. negative pressure extubation

Group Type SHAM_COMPARATOR

Lung-protective ventilation

Intervention Type PROCEDURE

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;

negative pressure extubation

Intervention Type PROCEDURE

The suction tube is inserted into the endotracheal tube, continuous negative pressure suction, and at the same time that the balloon is completely deflated, the suction tube, dental pad and endotracheal intubation are pulled out at the same time, and then the patient is instructed to cough independently and remove sputum.

Group of positive pressure extubation (Part II experiment)

1. lung-protective ventilation;
2. positive pressure extubation

Group Type EXPERIMENTAL

Lung-protective ventilation

Intervention Type PROCEDURE

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;

positive pressure extubation

Intervention Type PROCEDURE

The adjustable pressure limiting(APL)was adjusted to 30cm H2O, and after the patient breathed spontaneously until the peak airway pressure reached 30cm H2O, and after maintaining this level for 10s, the balloon was quickly cut off to remove the endotracheal tube, so that the patient had an autonomous coughing action, and then the oral sputum was removed.

Group of breathing training (Part II experiment)

1. lung-protective ventilation;
2. negative pressure extubation;
3. postoperative breathing training

Group Type EXPERIMENTAL

Lung-protective ventilation

Intervention Type PROCEDURE

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;

negative pressure extubation

Intervention Type PROCEDURE

The suction tube is inserted into the endotracheal tube, continuous negative pressure suction, and at the same time that the balloon is completely deflated, the suction tube, dental pad and endotracheal intubation are pulled out at the same time, and then the patient is instructed to cough independently and remove sputum.

postoperative breathing training

Intervention Type PROCEDURE

Inhale deeply through the nose, hold the breath for 5s, and then slowly spit out the breath through the mouth, cycle 5-6 times, and inflate the balloon. The above steps need to be performed 15 times within 24 hours after surgery.

Group of positive pressure extubation & breathing training (Part II experiment)

1. lung-protective ventilation;
2. positive pressure extubation;
3. postoperative breathing training

Group Type EXPERIMENTAL

Lung-protective ventilation

Intervention Type PROCEDURE

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;

positive pressure extubation

Intervention Type PROCEDURE

The adjustable pressure limiting(APL)was adjusted to 30cm H2O, and after the patient breathed spontaneously until the peak airway pressure reached 30cm H2O, and after maintaining this level for 10s, the balloon was quickly cut off to remove the endotracheal tube, so that the patient had an autonomous coughing action, and then the oral sputum was removed.

postoperative breathing training

Intervention Type PROCEDURE

Inhale deeply through the nose, hold the breath for 5s, and then slowly spit out the breath through the mouth, cycle 5-6 times, and inflate the balloon. The above steps need to be performed 15 times within 24 hours after surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Traditional ventilation strategies

1. Tidal volume:10ml/kg predicted body weight(PBW);
2. 0 cm H2O positive end expiratory pressure(PEEP);
3. negative pressure extubation

Intervention Type PROCEDURE

Traditional lung-protective ventilation strategies

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;
3. Ventilator-controlled recruitment manoeuvre;
4. CPAP;
5. negative pressure extubation

Intervention Type PROCEDURE

Innovative lung-protective ventilation strategies

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;
3. positive pressure extubation;
4. postoperative breathing training

Intervention Type PROCEDURE

Lung-protective ventilation

1. Tidal volume:6ml/kg PBW;
2. 5cmH2O PEEP;

Intervention Type PROCEDURE

negative pressure extubation

The suction tube is inserted into the endotracheal tube, continuous negative pressure suction, and at the same time that the balloon is completely deflated, the suction tube, dental pad and endotracheal intubation are pulled out at the same time, and then the patient is instructed to cough independently and remove sputum.

Intervention Type PROCEDURE

positive pressure extubation

The adjustable pressure limiting(APL)was adjusted to 30cm H2O, and after the patient breathed spontaneously until the peak airway pressure reached 30cm H2O, and after maintaining this level for 10s, the balloon was quickly cut off to remove the endotracheal tube, so that the patient had an autonomous coughing action, and then the oral sputum was removed.

Intervention Type PROCEDURE

postoperative breathing training

Inhale deeply through the nose, hold the breath for 5s, and then slowly spit out the breath through the mouth, cycle 5-6 times, and inflate the balloon. The above steps need to be performed 15 times within 24 hours after surgery.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Elderly patients aged ≥ 60 years old who undergo laparoscopic abdominal surgery;
2. Body mass index(BMI) \<30;
3. American society of anesthesiologists physical status classification system(ASA):I-III;
4. When the patient inhales air before surgery, SPO2≥94%;
5. The duration of the operation is 2-7 hours, and the pneumoperitoneal pressure is 10-14mmHg.

Exclusion Criteria

1. Patients with acute respiratory distress syndrome or pulmonary hypertension (pulmonary systolic blood pressure ≥ 40mmHg) or bronchiectasis or lung malignant tumors
2. Patients with acute respiratory infections within one month before surgery
3. Patients who have undergone cardiopulmonary surgery
4. Receiving invasive mechanical ventilation for more than 30min within 30 days before surgery
5. Patients with peak airway pressure \> 35 cm H2O during intraoperative mechanical ventilation
6. Patients with severe organic lesions of the heart such as obvious heart failure and coronary heart disease
7. Patients with preoperative anemia (Hb\<10g/L)
8. Patients with hypoproteinemia before surgery (albumin \< 35 g/L)
9. Patients with tracheostomy and severe difficult airway
10. Patients with sleep apnea syndrome
11. Patients with intraoperative heavy bleeding (50% of the circulating blood volume is lost ≥ 3 hours)
12. Patients with mental illness, impaired consciousness and communication disorders
13. Patients who refuse to participate in this trial
Minimum Eligible Age

60 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Affiliated Hospital of Nanchang University

OTHER

Sponsor Role collaborator

The First Hospital of Putian City, Putian, Fujian

OTHER_GOV

Sponsor Role collaborator

Fujian Medical University Union Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zhongmeng Lai

Role: PRINCIPAL_INVESTIGATOR

Fujian Medical University Union Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fujian Medical University Union Hospital

Fuzhou, Fujian, China

Site Status RECRUITING

The First Hospital of Putian

Putian, Fujian, China

Site Status NOT_YET_RECRUITING

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lingli Pan

Role: CONTACT

+86 18065184976

Zhongmeng Lai

Role: CONTACT

+86 13395000771

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lingli Pan

Role: primary

+86 18065184976

Huan Chen

Role: primary

+86 15080007150

Jia Min

Role: primary

+86 13970899291

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021MZK04KY

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.